BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 24756697)

  • 1. Polyserase-1/TMPRSS9 induces pro-tumor effects in pancreatic cancer cells by activation of pro-uPA.
    Fontanil T; Mohamedi Y; Esteban MM; Obaya AJ; Cal S
    Oncol Rep; 2014 Jun; 31(6):2792-6. PubMed ID: 24756697
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serase-1B, a new splice variant of polyserase-1/TMPRSS9, activates urokinase-type plasminogen activator and the proteolytic activation is negatively regulated by glycosaminoglycans.
    Okumura Y; Hayama M; Takahashi E; Fujiuchi M; Shimabukuro A; Yano M; Kido H
    Biochem J; 2006 Dec; 400(3):551-61. PubMed ID: 16872279
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification and characterization of human polyserase-3, a novel protein with tandem serine-protease domains in the same polypeptide chain.
    Cal S; Peinado JR; Llamazares M; Quesada V; Moncada-Pazos A; Garabaya C; López-Otín C
    BMC Biochem; 2006 Mar; 7():9. PubMed ID: 16566820
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pericellular activation of hepatocyte growth factor by the transmembrane serine proteases matriptase and hepsin, but not by the membrane-associated protease uPA.
    Owen KA; Qiu D; Alves J; Schumacher AM; Kilpatrick LM; Li J; Harris JL; Ellis V
    Biochem J; 2010 Feb; 426(2):219-28. PubMed ID: 20015050
    [TBL] [Abstract][Full Text] [Related]  

  • 5. TMPRSS4 upregulates uPA gene expression through JNK signaling activation to induce cancer cell invasion.
    Min HJ; Lee Y; Zhao XF; Park YK; Lee MK; Lee JW; Kim S
    Cell Signal; 2014 Feb; 26(2):398-408. PubMed ID: 23978400
    [TBL] [Abstract][Full Text] [Related]  

  • 6. TMPRSS4 induces cancer cell invasion through pro-uPA processing.
    Min HJ; Lee MK; Lee JW; Kim S
    Biochem Biophys Res Commun; 2014 Mar; 446(1):1-7. PubMed ID: 24434139
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interleukin-1alpha enhances the aggressive behavior of pancreatic cancer cells by regulating the alpha6beta1-integrin and urokinase plasminogen activator receptor expression.
    Sawai H; Okada Y; Funahashi H; Matsuo Y; Takahashi H; Takeyama H; Manabe T
    BMC Cell Biol; 2006 Feb; 7():8. PubMed ID: 16504015
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human polyserase-2, a novel enzyme with three tandem serine protease domains in a single polypeptide chain.
    Cal S; Quesada V; Llamazares M; Díaz-Perales A; Garabaya C; López-Otín C
    J Biol Chem; 2005 Jan; 280(3):1953-61. PubMed ID: 15536082
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Extracellular matrix metalloproteinase inducer up-regulates the urokinase-type plasminogen activator system promoting tumor cell invasion.
    Quemener C; Gabison EE; Naïmi B; Lescaille G; Bougatef F; Podgorniak MP; Labarchède G; Lebbé C; Calvo F; Menashi S; Mourah S
    Cancer Res; 2007 Jan; 67(1):9-15. PubMed ID: 17210677
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Overexpression of urokinase-type plasminogen activator in pancreatic adenocarcinoma is regulated by constitutively activated RelA.
    Wang W; Abbruzzese JL; Evans DB; Chiao PJ
    Oncogene; 1999 Aug; 18(32):4554-63. PubMed ID: 10467400
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Polyserase-I, a human polyprotease with the ability to generate independent serine protease domains from a single translation product.
    Cal S; Quesada V; Garabaya C; Lopez-Otin C
    Proc Natl Acad Sci U S A; 2003 Aug; 100(16):9185-90. PubMed ID: 12886014
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interaction between cancer cells and stromal fibroblasts is required for activation of the uPAR-uPA-MMP-2 cascade in pancreatic cancer metastasis.
    He Y; Liu XD; Chen ZY; Zhu J; Xiong Y; Li K; Dong JH; Li X
    Clin Cancer Res; 2007 Jun; 13(11):3115-24. PubMed ID: 17545513
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Osteopontin: it's role in regulation of cell motility and nuclear factor kappa B-mediated urokinase type plasminogen activator expression.
    Das R; Philip S; Mahabeleshwar GH; Bulbule A; Kundu GC
    IUBMB Life; 2005 Jun; 57(6):441-7. PubMed ID: 16012053
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Targeting of urokinase plasminogen activator receptor in human pancreatic carcinoma cells inhibits c-Met- and insulin-like growth factor-I receptor-mediated migration and invasion and orthotopic tumor growth in mice.
    Bauer TW; Liu W; Fan F; Camp ER; Yang A; Somcio RJ; Bucana CD; Callahan J; Parry GC; Evans DB; Boyd DD; Mazar AP; Ellis LM
    Cancer Res; 2005 Sep; 65(17):7775-81. PubMed ID: 16140945
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Significant down-regulation of the plasminogen activator inhibitor 1 mRNA in pancreatic cancer.
    Warnecke-Eberz U; Prenzel KL; Baldus SE; Metzger R; Dienes HP; Bollschweiler E; Hoelscher AH; Schneider PM
    Pancreas; 2008 Mar; 36(2):173-7. PubMed ID: 18376309
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification and analysis of the promoter region of the type II transmembrane serine protease polyserase-1 and its transcript variants.
    Hayama M; Okumura Y; Takahashi E; Shimabukuro A; Tamura M; Takeda N; Kubo T; Kido H
    Biol Chem; 2007 Aug; 388(8):853-8. PubMed ID: 17655505
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Roles and regulation of membrane-associated serine proteases.
    Qiu D; Owen K; Gray K; Bass R; Ellis V
    Biochem Soc Trans; 2007 Jun; 35(Pt 3):583-7. PubMed ID: 17511657
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Use of IHC and newly designed matriptase inhibitors to elucidate the role of matriptase in pancreatic ductal adenocarcinoma.
    Uhland K; Siphos B; Arkona C; Schuster M; Petri B; Steinmetzer P; Mueller F; Schweinitz A; Steinmetzer T; Van De Locht A
    Int J Oncol; 2009 Aug; 35(2):347-57. PubMed ID: 19578749
    [TBL] [Abstract][Full Text] [Related]  

  • 19. TMPRSS4 promotes invasion, migration and metastasis of human tumor cells by facilitating an epithelial-mesenchymal transition.
    Jung H; Lee KP; Park SJ; Park JH; Jang YS; Choi SY; Jung JG; Jo K; Park DY; Yoon JH; Park JH; Lim DS; Hong GR; Choi C; Park YK; Lee JW; Hong HJ; Kim S; Park YW
    Oncogene; 2008 Apr; 27(18):2635-47. PubMed ID: 17968309
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A novel transmembrane serine protease (TMPRSS3) overexpressed in pancreatic cancer.
    Wallrapp C; Hähnel S; Müller-Pillasch F; Burghardt B; Iwamura T; Ruthenbürger M; Lerch MM; Adler G; Gress TM
    Cancer Res; 2000 May; 60(10):2602-6. PubMed ID: 10825129
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.